Results 51 to 60 of about 126,231 (300)
Management of infantile subglottic hemangioma: Laser vaporization, submucous resection, intubation, or intralesional steroids? [PDF]
, 1997 The infantile subglottic hemangioma can be treated in various ways. The results of the treatment used in the Sophia Children's Hospital, intralesional steroids and intubation (IS + I), are discussed and compared with the results of other current ...
Hoeve, L.J. (Hans) +2 more
core +2 more sources
Infantile Hemangioma: A Review of Current Pharmacotherapy Treatment and Practice Pearls.
The Journal of Pediatric Pharmacology and Therapeutics, 2020 Infantile hemangioma (IH) is the most common vascular tumor of infancy, affecting as many as 5% to 10% of all infants. The exact cause is unclear, but specific risk factors, such as low birth weight, prematurity, female sex, white race, and family ...
Laura Tiemann, S. Hein
semanticscholar +1 more source
Propranolol for Infantile Hemangiomas [PDF]
Global Advances in Health and Medicine, 2012 Hemangiomas are common vascular birthmarks that usually present a predictable pattern of proliferation and ultimate involution. Most do not require any treatment. When intervention is clinically indicated, medical and surgical options exist. Historically, corticosteroids have been used and have been shown to slow or stop the growth of a majority of ...
openaire +3 more sources
Infantile hemangioma in a V2 distribution: Treatment with nadolol
Journal of Family Medicine and Primary Care, 2015 Infantile hemangiomas are common benign tumours of infancy affecting up to 10% of children. They are typically not present at birth but undergo a rapid proliferation stage and then plateau in growth before resolving spontaneously. Recently, beta-blockers
Mariah Giberson, Robert Hayes
doaj +1 more source
The Infantile Hemangioma Referral Score: A Validated Tool for Physicians
Pediatrics, 2020 We present the IHReS, an easy-to-use, validated, and reliable referral instrument for primary physicians to ensure that patients with IH receive timely optimal care.
C. Léauté-Labrèze +7 more
semanticscholar +1 more source
Journal of Baghdad College of Dentistry, 2016 Background: Sclerotherapy is a simple treatment modality for treatment of infantile hemangioma and slow-flow vascular malformations; Polidocanol is a mild sclerosing agent that is traditionally used in treatment of varicose veins.
Suhail Ibraheem Kadhum +1 more
doaj +1 more source
Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis [PDF]
, 2014 Infantile hemangiomas (IHs) are non-malignant, largely cutaneous vascular tumors affecting approximately 5–10% of children to varying degrees. During the first year of life, these tumors are strongly proliferative, reaching an average size ranging from 2
AMAYA, CLARISSA +10 more
core +1 more source
Propranolol in the Treatment of Infantile Hemangiomas
Clinical, Cosmetic and Investigational Dermatology, 2021 Propranolol, as the first generation of β-blocker family, was initially introduced in the clinical application for tachycardia and hypertension in the 1960s. However, the occasional discovery of propranolol in the involution of infantile hemangiomas (IHs) brought us a new perspective.
Xin Tan, Shu Guo, Chenchao Wang
openaire +5 more sources
口腔疾病防治, 2021 Hemangiomas and vascular malformations are common clinical diseases. According to their clinical and imaging characterizations, the International Society for the Study of Vascular Anomalies (ISSVA) has systematically classified infantile hemangioma and ...
ZHENG Jiawei, ZHAO Zeliang
doaj +1 more source
Signaling pathways in the development of infantile hemangioma [PDF]
, 2014 Infantile hemangioma (IH), which is the most common tumor in infants, is a benign vascular neoplasm resulting from the abnormal proliferation of endothelial cells and pericytes.
Bo Xiang +5 more
core +1 more source